Atovaquon/Proguanilhydrochlorid Amarox

Atovaquone/Proguanil Hydrochloride by Amarox Pharma Gmbh is an oral medication used for malaria prevention and treatment. This combination therapy is designed to combat malaria-causing parasites.

Atovaquone/Proguanil Hydrochloride is primarily used for the prevention and treatment of malaria, a mosquito-borne disease caused by parasites. This medication works by interfering with the growth and reproduction of the parasites in the body. It is often prescribed for travelers to areas where malaria is prevalent, helping to protect against infection. The combination of atovaquone and proguanil hydrochloride provides a broad-spectrum approach to combating malaria.

Common effects of Atovaquone/Proguanil Hydrochloride may include nausea, vomiting, diarrhea, and stomach pain. Some users might experience headache, dizziness, or weakness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Atovaquone/Proguanil Hydrochloride should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment to ensure effectiveness. This medication should be stored at room temperature and kept out of reach of children.

Atovaquone/Proguanil Hydrochloride may interact with certain medications, including antacids, metoclopramide, and drugs that affect the liver's ability to metabolize other medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication.